GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
393.49
+13.26 (3.49%)
At close: Apr 17, 2026
GlaxoSmithKline Pakistan Market Cap
GlaxoSmithKline Pakistan has a market cap or net worth of 125.31 billion as of April 17, 2026. Its market cap has decreased by -5.45% in one year.
Market Cap
125.31B
Enterprise Value
117.34B
Revenue
65.90B
Ranking
n/a
PE Ratio
12.50
Stock Price
393.49
Market Cap Chart
Since September 26, 1994, GlaxoSmithKline Pakistan's market cap has increased from 3.77B to 125.31B, an increase of 3,223.22%. That is a compound annual growth rate of 11.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 125.31B | 0.95% |
| Dec 31, 2025 | 124.13B | -1.80% |
| Dec 31, 2024 | 126.40B | 378.26% |
| Dec 29, 2023 | 26.43B | -5.45% |
| Dec 30, 2022 | 27.95B | -35.70% |
| Dec 31, 2021 | 43.47B | -28.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott Laboratories (Pakistan) | 95.59B |
| The Searle Company | 55.93B |
| Highnoon Laboratories | 54.51B |
| AGP Limited | 52.98B |
| Citi Pharma | 18.77B |
| Ferozsons Laboratories | 17.64B |
| Macter International | 13.64B |
| Otsuka Pakistan | 4.56B |